American Healthcare REIT, Inc. (AHR) P/E Ratio History
Historical price-to-earnings valuation from 2025 to 2025
Loading P/E history...
AHR Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 8, 2026, American Healthcare REIT, Inc. (AHR) trades at a price-to-earnings ratio of 118.1x, with a stock price of $49.60 and trailing twelve-month earnings per share of $0.42.
The current P/E is 44% below its 5-year average of 209.7x. Over the past five years, AHR's P/E has ranged from a low of 115.2x to a high of 304.2x, placing the current valuation at the 50th percentile of its historical range.
Compared to the Real Estate sector median P/E of 24.2x, AHR trades at a 387% premium to its sector peers. The sector includes 171 companies with P/E ratios ranging from 1.1x to 196.6x.
The PEG ratio of 1.77 (P/E divided by 245% EPS growth) suggests a fair valuation relative to its earnings growth. Peter Lynch popularized the rule that a PEG below 1.0 indicates an attractive entry point.
Relative to the broader market, AHR commands a significant premium over the S&P 500 median P/E of 25.1x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our AHR DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
AHR P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $149B | 153.3 | - | -11% | |
| $41B | 160.3 | - | +184%Best | |
| $14B | 196.6 | - | -72% | |
| $14B | 23.8 | 1.02Best | +25% | |
| $5B | 32.2 | - | +19% | |
| $2B | 15.3Lowest | - | +24% | |
| $9B | 25.2 | 1.19 | +96% | |
| $4B | 24.9 | - | -4% | |
| $94M | 115.3 | - | -95% |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
AHR Historical P/E Data (2025–2025)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2025 Q4 | Wed Dec 31 2025 00:00:00 GM | $47.06 | $0.41 | 115.2x | -45% |
| FY2025 Q3 | $42.01 | $0.14 | 304.2x | +45% |
Average P/E for displayed period: 209.7x
Full AHR Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
See AHR's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs AHR Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare AHR vs WELL
Side-by-side business, growth, and profitability comparison vs Welltower Inc..
Start ComparisonAHR — Frequently Asked Questions
Quick answers to the most common questions about buying AHR stock.
Is AHR stock overvalued or undervalued?
AHR trades at 118.1x P/E, below its 5-year average of 209.7x. At the 50th percentile of historical range, the stock is priced at a discount to its own history.
How does AHR's valuation compare to peers?
American Healthcare REIT, Inc. P/E of 118.1x compares to sector median of 24.2x. The premium reflects expected growth above peers.
What is AHR's PEG ratio?
AHR PEG ratio is 1.77. Between 1-2 suggests valuation aligns with growth. Historical P/E data spans 2025-2025.